Loading page content…
Loading page content…
Loading contract search results…
Loading contract details…
| Source: | Find a Tender Service (FTS) |
| Notice Type: | Planning update |
| Buyer: | NHS England |
| Main Category: | Goods |
| Procurement Method: | — |
| Tender Status: | Pre-tender |
Pipeline status
Not addedImports the contract into your BidWriter pipeline · Qualify before you commit to bid
Application Deadline
17 November 2026
14 days left
Estimated Value
£128,400,000
Need help writing this bid?
Our specialists write winning tender responses. Free consultation, no obligation.
Book a free consultation →| Estimated Value (ex. VAT): | £128,400,000 |
| Estimated Value (inc. VAT): | £154,080,000 |
| Release Date: | 3 November 2026 |
| Application Deadline: | 17 November 2026 |
| Contract Start Date: | 30 September 2027 (Estimated) |
| Contract End Date: | 30 September 2029 (Estimated) |
| Contract Duration: | 2.0 years |
| Procurement ID (OCID): | ocds-h6vhtk-0668c2 |
| Notice Reference: | 104326-2026 |
Ready to bid on this contract?
BidWriter AI writes your tender response in minutes — import this contract in one click.
View Original Notice
Access the full notice on the official portal
Title updated to "NHS National Framework Agreement for Macitentan & Cladribine Tablets"
Project title: NHS National Framework Agreement for Macitentan & Cladribine Tablets Offer reference number: CM/TNS/26/5748 Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to a maximum of 24 months. CM/TNS/26/5748/01 Macitentan Lot 1 DCE/DLN: 1/10/2027 to 30/09/2029 (24 months) CELN Lot 2 DNW/DLS: 1/10/2027 to 31/01/2029 (16 months) NWLS Lot 3 DNE/DSW: 1/10/2027 to 30/09/2029 (24 months) NESW CM/TNS/26/5748/02 Cladribine Tablets Lot 1 DCE/DSW: 1/10/2027 to 30/09/2029 (24 months) CESW Lot 2 DLN/DNW: 1/10/2027 to 31/01/2029 (16 months) NWLN Lot 3 DLS/DNE: 1/10/2027 to 30/09/2028 (12 months) LSNE Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England